Stay updated with the latest glaxosmithkline-pharmaceuticals news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on glaxosmithkline-pharmaceuticals topics.
New Delhi, Delhi, India - Business Wire India Sensodyne, Haleon's leading oral care brand, is strengthening its commitment to better oral health in India with the launch of its 'Know Your Dental Age' initiative, placing the concept of Dental Age at the forefront of proactive care. India continues to face a significant oral health gap, with 9 in 10 people experiencing dental issues and most seeking treatment only when symptoms become severe. To drive early awareness and encourage preventive habi ...Read More >
New Delhi, Delhi, India - Sensodyne, Haleon's leading oral care brand, is strengthening its commitment to better oral health in India with the launch of its 'Know Your Dental Age' initiative, placing the concept of Dental Age at the forefront of proactive care. India continues to face a significant oral health gap, with 9 in 10 people experiencing dental issues and most seeking treatment only when symptoms become severe. To drive early awareness and encourage preventive habits, Sensodyne has par ...Read More >
PRNewswire New Delhi [India], March 30: Sensodyne, Haleon's leading oral care brand, is strengthening its commitment to better oral health in India with the launch of its 'Know Your Dental Age' initiative, placing the concept of Dental Age at the forefront of proactive care. India continues to face a significant oral health gap, with 9 in 10 people experiencing dental issues and most seeking treatment only when symptoms become severe. To drive early awareness and encourage preventive habits, Se ...Read More >
New Delhi, Nov 6 (PTI) GlaxoSmithKline Pharmaceuticals on Thursday posted a 2 per cent year-on-year increase in its net profit to Rs 255 crore in the second quarter ended September 30, 2025. The drug firm reported a net profit of Rs 249 crore during the July-September quarter of the last fiscal. Revenue from operations, however, declined to Rs 974 crore in the September quarter as against Rs 1,000 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a regulatory filing. Topli ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.